Non-Squamous Non-Small Cell Lung Cancer Not Yet Recruiting Phase Trials for Anlotinib (DB11885)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Not Yet RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03671538Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and CisplatinTreatment
NCT03602027Phase I Study of the Combination of Anlotinib With GefitinibTreatment
NCT03566576Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelTreatment